Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) (PAR-27-026)
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional): (PAR-27-026). Dated 148 days ago, it serves as a historical benchmark. Score 80/100. As of 2026-11-03, from Grants.gov (U.S. Department of Health and Human Services).
Data as of · Compiled by Zalwin from Grants.gov (U.S. Department of Health and Human Services)
Free preview: all 15 published fields of this record are shown below. Locked: 111 related GrantPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Opportunity number | PAR-27-026 |
| Title | Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) |
| Agency | National Institutes of Health |
| Status | posted |
| Posted / open date | 2026-06-09 |
| Close date | 2028-09-25 |
| Award ceiling | n/a |
| Award floor | n/a |
| Estimated total funding | n/a |
| Funding category | Health |
| Eligible applicants | City or township governments; Special district governments; Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Public and State controlled institutions of higher education; Public housing authorities/Indian housing authorities; Private institutions of higher education; Small businesses; County governments; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts; Native American tribal governments (Federally recognized); Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; For profit organizations other than small businesses; Native American tribal organizations (other than Federally recognized tribal governments) |
| Eligibility notes | Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
| CFDA / Assistance listing | 93.279 |
| Summary | The purpose of this notice of funding opportunity (NOFO) is to support innovative basic, clinical, translational, and implementation science research relevant to HIV and substance use. This initiative encourages high risk high impact transformative studies that advance knowledge and strategies for HIV prevention, diagnosis, treatment and virus suppression in people who use substances and/or have a substance use disorder. |
| Agency contact | [email protected] |
| Peer records CSV (112 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) + all 112 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Opportunity · Agency · Status · Award ceiling · Closes · official source URL
- Source agency: Grants.gov (U.S. Department of Health and Human Services)
- Record date: 2026-06-09
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top GrantPulse records (HHS first): Children’s Hospitals Graduate Medical Education (CHGME · Centers of Excellence in Healthcare Quality and Safety (CDC- · Title X Family Planning Services Grants (PA-FPH-27-001) · Development of Collaborative Research Facilities or Research · Emerging Infections Network - Research for Preventing, Detec · Browse all by state and category →
LIVE PUBLIC DATA Source: Grants.gov (U.S. Department of Health and Human Services) · Last refreshed: Tue, 03 Nov 2026 18:08:06 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) and 112 HHS peers
- HHS GrantPulse records like this one: 112
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every HHS peer: $22,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
80 / 100 Plain-English Eligibility Score
- Small businesses are listed as eligible applicants.
- Nonprofits are listed as eligible applicants.
- 691 days until the deadline: enough time to prepare a strong application.
What is the GrantPulse record for Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)?
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) (PAR-27-026) from National Institutes of Health: posted, award ceiling n/a.
How does Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) compare to other GrantPulse records?
It is 148 days old; check the official source for later updates before acting. Its Plain-English Eligibility Score of 80/100 puts it among the stronger signals in this feed.
Get the readiness pack for this opportunity ($4.99)
Eligibility summary, registrations checklist, deadline timeline and a proposal outline, generated from this notice.
Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) vs. top 3 peers
| Organization | Location | Combined award ceilings | Percentile | Record date |
|---|---|---|---|---|
| Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) | HHS | 2026-06-09 | ||
| Rural Communities Opioid Response Program - Overdose Response | HHS | $300,000 | 19th | 2026-08-21 |
| Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health | HHS | $1,000,000 | 59th | 2026-08-21 |
| Rural Communities Opioid Response Program - Community Systems Development | HHS | $500,000 | 35th | 2026-08-14 |
Related records
- Rural Communities Opioid Response Program - Overdose Response
- Rural Communities Opioid Response Program - Child and Adolescent Behavioral Health
- Rural Communities Opioid Response Program - Community Systems Development
- Healthy Tomorrows Partnership for Children Program (HTPCP)
- Rural Residency Planning and Development Program
- Rural Health Value Program
- The National Network of STI Prevention Training Centers (NNPTC)
- Comprehensive Suicide Prevention Program for States
- NIOSH Small Research Grant Program (R03)
- NIOSH National Center of Excellence for the Prevention of Childhood Agricultural Injury (U54)
- Research Grants to Rigorously Evaluate Innovative and Promising Approaches to Prevent Firearm-Related Violence and Injuries
- Cooperative Research Agreements Related to the World Trade Center Health Program (U01)
Open and upcoming HHS federal grants Open and upcoming federal grants: Health
How to monitor Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) and peer health records
Get new GrantPulse records like Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new grants that fit you every week
GrantPulse emails new and forecasted grants matching your organization type and focus areas.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.
Often used together
- FormDPulse
- NsfAwardPulse
- Public Works Prevailing Wage Intent + Environmental Remediation & Tank Retrofit Multi-Signal Trigger
- ContentVelocityRadar
- B2BDomainSignalVerify
- PodcastSponsorRadar
Or get the Advisor Prospecting Bundle for $14.99 one-time: Full CSV unlock of newly funded companies plus a grant readiness pack.